Viking Therapeutics, Inc. Treasury Stock, Value
Viking Therapeutics, Inc. (VKTX) had Treasury Stock, Value of $0 as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-02-11
- 2025-12-31: Treasury Stock, Value $0.00.
- 2025-09-30: Treasury Stock, Value $0.00.
- 2025-06-30: Treasury Stock, Value $0.00.
- 2025-03-31: Treasury Stock, Value $0.00.
| Period end | Treasury Stock, Value |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-11 |
| 2025-09-30 | $0.00 10-Q · filed 2025-10-23 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-23 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-24 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-11 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-23 |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-24 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-25 |
| 2023-12-31 | $6.79M 10-K · filed 2025-02-26 |
| 2023-09-30 | $6.79M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $6.79M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $6.79M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $6.79M 10-K · filed 2024-02-07 |
| 2022-09-30 | $6.79M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $6.79M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $5.12M 10-Q · filed 2022-04-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |